Effect of intensive glycemic control on platelet reactivity in patients with long-standing uncontrolled diabetes

Thrombosis Research

Volumn 134, Issue 1, 2014, Pages 121-124

  Singer, Joelle ^a   Weissler Snir, Adaya ^b   Leshem Lev, Dorit ^b   Rigler, Merav ^a   Kornowski, Ran ^b   Lev, Eli I ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Diabetes; glycemic control; glycosylated hemoglobin; platelet reactivity

Indexed keywords

GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; BLOOD; BLOOD CLOTTING PARAMETERS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; THROMBOCYTE; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PLATELET FUNCTION TESTS; YOUNG ADULT;

EID: 84902552050     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.05.010     Document Type: Article

References (36)

1. G. Roglic, N. Unwin, P.H. Bennett, C. Mathers, J. Tuomilehto, and S. Nag et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000 Diabetes Care 28 2005 2130 2135
2. M.W. Webster, and R.S. Scott What cardiologists need to know about diabetes Lancet 350 Suppl. 1 1997 SI23 SI28
3. K. Malmberg, S. Yusuf, H.C. Gerstein, J. Brown, F. Zhao, and D. Hunt et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry Circulation 102 2000 1014 1019
4. M. Roffi, D.P. Chew, D. Mukherjee, D.L. Bhatt, J.A. White, and C. Heeschen et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes Circulation 104 2001 2767 2771
5. V. Fuster, P.R. Moreno, Z.A. Fayad, R. Corti, and J.J. Badimon Atherothrombosis and high-risk plaque, part I: evolving concepts J Am Coll Cardiol 46 2005 937 954
6. G. DavI, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
7. L.K. Jennings Role of platelets in atherothrombosis Am J Cardiol 103 2009 4A 10A [Suppl.]
8. H.F. Langer, and M. Gawaz Platelet-vessel wall interactions in atherosclerotic disease Thromb Haemost 99 2008 480 486
9. D.J. Angiolillo, E. Bernardo, M. Sabaté, P. Jimenez-Quevedo, M.A. Costa, and J. Palazuelos et al. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease J Am Coll Cardiol 50 2007 1541 1547
10. M.A. Creager, T.F. Lüscher, F. Cosentino, and J.A. Beckman Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I Circulation 108 2003 1527 1532
11. B. Stratmann, and D. Tschoepe Pathobiology and cell interactions of platelets in diabetes Diab Vasc Dis Res 2 2005 16 23
12. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, C. Ramírez, M. Sabaté, and P. Jimenez-Quevedo et al. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment Diabetes 54 2005 2430 2435
13. A.I. Vinik, T. Erbas, T.S. Park, R. Nolan, and G.L. Pittenger Platelet dysfunction in type 2 diabetes Diabetes Care 24 2001 1476 1485
14. P. Ferroni, S. Basili, A. Falco, and G. Davì Platelet activation in type 2 diabetes mellitus J Thromb Haemost 2 2004 1282 1291
15. H. Arjomand, B. Roukoz, S.K. Surabhi, and M. Cohen Platelets and antiplatelet therapy in patients with diabetes mellitus J Invasive Cardiol 15 2003 264 269
16. I. Aoki, K. Shimoyama, N. Aoki, M. Homori, A. Yanagisawa, and K. Nakahara et al. Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes Am Coll Cardiol 27 3 Mar 1 1996 560 566
17. J.L. Ferreiro, and D.J. Angiolillo Diabetes and antiplatelet therapy in acute coronary syndrome Circulation 123 2011 798 813
18. T. Geisler, N. Anders, M. Paterok, H. Langer, K. Stellos, and S. Lindemann et al. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation Diabetes Care 30 2007 372 374
19. D.J. Angiolillo, E. Bernardo, C. Ramírez, M.A. Costa, M. Sabaté, and P. Jimenez-Quevedo et al. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment J Am Coll Cardiol 48 2006 298 304
20. José Luis Ferreiro, and Dominick J. Angiolillo Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome Circulation 123 2011 798 813
21. D.J. Schneider Factors contributing to increased platelet reactivity in people with diabetes Diabetes Care 32 2009 525 527
22. E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F.L. Brancati, and N.R. Powe et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus Ann Intern Med 141 6 Sep 21 2004 421 431
23. A. Shankar, R. Klein, B.E. Klein, and S.E. Moss Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes Am J Epidemiol 166 4 Aug 15 2007 393 402 [Epub 2007 May 25]
24. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development an progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
25. UK Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
26. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
27. ACCORD Study Group Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 364 2011 818 828
28. A. Singla, M.J. Antonino, K.P. Bliden, U.S. Tantry, and P.A. Gurbel The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy Am Heart J 158 5 2009 784.e1 784.e6
29. D. Vivas, J.C. García-Rubira, E. Bernardo, D.J. Angiolillo, P. Martín, and A. Calle-Pascual et al. Influence of HbA1c levels on platelet function profiles associated with tight glycemic control in patients presenting with hyperglycemia and an acute coronary syndrome. A subanalysis of the CHIPS Study J Thromb Thrombolysis 35 2 Feb 2013 165 174
30. D. Vivas, J.C. García-Rubira, E. Bernardo, D.J. Angiolillo, P. Martín, and A. Calle et al. Effect of an Optimized Treatment With Insulin on Platelet Reactivity After Discharge in Patients With an Acute Coronary Syndrome and Hyperglycemia Rev Esp Cardiol 64 1 2014 Jan 22 27 [pii: S0300-8932(13)00283-2]
31. F. Mangiacapra, A.J. Peace, W. Wijns, and E. Barbato Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel J Thromb Thrombolysis 32 1 Jul 2011 54 58 10.1007/s11239-010-0547-4
32. B. Gaborit, C. Frere, T. Cuisset, M.C. Alessi, and A. Dutour Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control J Thromb Haemost 7 11 2009 1939 1941
33. D.J. Angiolillo, E. Bernardo, C. Ramirez, M.A. Costa, M. Sabate, and P. Jimenez-Quevedo et al. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment J Am Coll Cardiol 48 2006 298 304
34. E. Wallerstedt, U. Smith, and C.X. Andersson Protein kinase C-δ is involved in the inflammatory effect of IL-6 in mouse adipose cells Diabetologia 53 2010 946
35. Refik Demirtunc, Dursun Duman, Melih Basar, Mustafa Bilgi, Mehmet Teomete, and Tayfun Garip The relationship between glycemic control and platelet activity in type 2 diabetes mellitus J Diabetes Complications 23 2009 89 94
36. T. Bouganim, Y. Shapira, A. Sagie, M. Vaturi, A. Battler, and R. Kornowski et al. Platelet reactivity in patients with a history of obstructive prosthetic valve thrombosis Am J Cardiol 103 12 Jun 15 2009 1760 1763